Abstract
MicroRNAs are small noncoding RNAs that regulate gene expression by binding to sequences within the 3′-UTR of mRNAs. Genome-wide screens have proven powerful in associating genes with certain phenotypes or signal transduction pathways and thus are valuable tools to define gene function. Here we describe a genome-wide miRNA screening strategy to identify miRNAs that are required to bypass oncogene-induced senescence.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Carnero A (2013) Markers of cellular senescence. Methods Mol Biol 965:63–81
Rodier F, Campisi J (2011) Four faces of cellular senescence. J Cell Biol 192(4):547–556
Coppe JP et al (2010) The senescence-associated secretory phenotype: the dark side of tumor suppression. Annu Rev Pathol 5:99–118
Barrett JC et al (1994) Cellular senescence and cancer. Cold Spring Harb Symp Quant Biol 59411–59418
Serrano M, Blasco MA (2001) Putting the stress on senescence. Curr Opin Cell Biol 13(6):748–753
Shay JW, Roninson IB (2004) Hallmarks of senescence in carcinogenesis and cancer therapy. Oncogene 23(16):2919–2933
Sharpless NE, DePinho RA (2004) Telomeres, stem cells, senescence, and cancer. J Clin Invest 113(2):160–168
Serrano M et al (1997) Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a. Cell 88(5):593–602
Vergel M et al (2010) Cellular senescence as a target in cancer control. J Aging Res 2011:725365
Ben-Porath I, Weinberg RA (2005) The signals and pathways activating cellular senescence. Int J Biochem Cell Biol 37(5):961–976
Roninson IB (2002) Tumor senescence as a determinant of drug response in vivo. Drug Resist Updat 5(5):204–208
Roninson IB (2003) Tumor cell senescence in cancer treatment. Cancer Res 63(11):2705–2715
Zhao H, Darzynkiewicz Z (2013) Biomarkers of cell senescence assessed by imaging cytometry. Methods Mol Biol 965:83–92
Collado M et al (2005) Tumour biology: senescence in premalignant tumours. Nature 436(7051):642
Chen Z et al (2005) Crucial role of p53-dependent cellular senescence in suppression of Pten-deficient tumorigenesis. Nature 436(7051):725–730
Michaloglou C et al (2005) BRAFE600-associated senescence-like cell cycle arrest of human naevi. Nature 436(7051):720–724
Narlik-Grassow M et al (2013) Conditional transgenic expression of PIM1 kinase in prostate induces inflammation-dependent neoplasia. PLoS One 8(4), e60277
Schmitt CA et al (2002) A senescence program controlled by p53 and p16INK4a contributes to the outcome of cancer therapy. Cell 109(3):335–346
Baudino TA et al (2003) Myc-mediated proliferation and lymphomagenesis, but not apoptosis, are compromised by E2f1 loss. Mol Cell 11(4):905–914
Schmitt CA et al (2002) Dissecting p53 tumor suppressor functions in vivo. Cancer Cell 1(3):289–298
Carnero A, Lleonart ME (2011) Epigenetic mechanisms in senescence, immortalisation and cancer. Biol Rev Camb Philos Soc 86(2):443–455
Feliciano A et al (2011) MicroRNAs regulate key effector pathways of senescence. J Aging Res 2011:205378
Olovnikov AM (1996) Telomeres, telomerase, and aging: origin of the theory. Exp Gerontol 31(4):443–448
Campisi J, d’Adda di Fagagna F (2007) Cellular senescence: when bad things happen to good cells. Nat Rev Mol Cell Biol 8(9):729–740
Pospelova TV, Chitikova ZV, Pospelov VA (2013) An integrated approach for monitoring cell senescence. Methods Mol Biol 965:383–408
de la Rosa J et al (2013) Prelamin A causes progeria through cell-extrinsic mechanisms and prevents cancer invasion. Nat Commun 4:2268
Itahana K, Itahana Y, Dimri GP (2013) Colorimetric detection of senescence-associated beta galactosidase. Methods Mol Biol 965:143–156
Bassaneze V, Miyakawa AA, Krieger JE (2013) Chemiluminescent detection of senescence-associated beta galactosidase. Methods Mol Biol 965:157–163
d’Adda di Fagagna F (2008) Living on a break: cellular senescence as a DNA-damage response. Nat Rev Cancer 8(7):512–522
d’Adda di Fagagna F et al (2003) A DNA damage checkpoint response in telomere-initiated senescence. Nature 426(6963):194–198
Herbig U et al (2004) Telomere shortening triggers senescence of human cells through a pathway involving ATM, p53, and p21(CIP1), but not p16(INK4a). Mol Cell 14(4):501–513
Ruiz L et al (2008) Characterization of the p53 response to oncogene-induced senescence. PLoS One 3(9), e3230
Hewitt G, von Zglinicki T, Passos JF (2013) Cell sorting of young and senescent cells. Methods Mol Biol 1048:31–47
Zhang W et al (2008) Comparison of global DNA methylation profiles in replicative versus premature senescence. Life Sci 83(13–14):475–480
Narita M et al (2003) Rb-mediated heterochromatin formation and silencing of E2F target genes during cellular senescence. Cell 113(6):703–716
Zhang H, Pan KH, Cohen SN (2003) Senescence-specific gene expression fingerprints reveal cell-type-dependent physical clustering of up-regulated chromosomal loci. Proc Natl Acad Sci U S A 100(6):3251–3256
Young AR, Narita M (2013) Cell senescence as both a dynamic and a static phenotype. Methods Mol Biol 965:1–13
Vistoli G et al (2013) Advanced glycoxidation and lipoxidation end products (AGEs and ALEs): an overview of their mechanisms of formation. Free Radic Res 47:3–27
Gasparovic AC et al (2013) Assays for the measurement of lipid peroxidation. Methods Mol Biol 965283–965296
Campisi J et al (2011) Cellular senescence: a link between cancer and age-related degenerative disease? Semin Cancer Biol 21(6):354–359
Campisi J (2011) Cellular senescence: putting the paradoxes in perspective. Curr Opin Genet Dev 21(1):107–112
Krtolica A et al (2001) Senescent fibroblasts promote epithelial cell growth and tumorigenesis: a link between cancer and aging. Proc Natl Acad Sci U S A 98(21):12072–12077
Bavik C et al (2006) The gene expression program of prostate fibroblast senescence modulates neoplastic epithelial cell proliferation through paracrine mechanisms. Cancer Res 66(2):794–802
Parrinello S et al (2005) Stromal-epithelial interactions in aging and cancer: senescent fibroblasts alter epithelial cell differentiation. J Cell Sci 118:118485–118496
Collado M, Serrano M (2006) The power and the promise of oncogene-induced senescence markers. Nat Rev Cancer 6(6):472–476
Carnero A, Link W, Martinez JF, Renner O, Castro ME, Blanco F et al (2003) Cellular senescence and cancer. Res Adv Cancer 3:183–198
Chandeck C, Mooi WJ (2010) Oncogene-induced cellular senescence. Adv Anat Pathol 17(1):42–48
Braig M, Schmitt CA (2006) Oncogene-induced senescence: putting the brakes on tumor development. Cancer Res 66(6):2881–2884
Courtois-Cox S, Jones SL, Cichowski K (2008) Many roads lead to oncogene-induced senescence. Oncogene 27(20):2801–2809
Bartek J, Bartkova J, Lukas J (2007) DNA damage signalling guards against activated oncogenes and tumour progression. Oncogene 26(56):7773–7779
Ruzankina Y, Asare A, Brown EJ (2008) Replicative stress, stem cells and aging. Mech Ageing Dev 129(7–8):460–466
Kenyon J, Gerson SL (2007) The role of DNA damage repair in aging of adult stem cells. Nucleic Acids Res 35(22):7557–7565
Di Micco R et al (2006) Oncogene-induced senescence is a DNA damage response triggered by DNA hyper-replication. Nature 444(7119):638–642
Passos JF, Von Zglinicki T (2006) Oxygen free radicals in cell senescence: are they signal transducers? Free Radic Res 40(12):1277–1283
Parrinello S et al (2003) Oxygen sensitivity severely limits the replicative lifespan of murine fibroblasts. Nat Cell Biol 5(8):741–747
Vergel M, Carnero A (2010) Bypassing cellular senescence by genetic screening tools. Clin Transl Oncol 12(6):410–417
Malumbres M, Carnero A (2003) Cell cycle deregulation: a common motif in cancer. Prog Cell Cycle Res 5:5–18
Blagosklonny MV (2012) Cell cycle arrest is not yet senescence, which is not just cell cycle arrest: terminology for TOR-driven aging. Aging 4(3):159–165
Schmitt CA (2007) Cellular senescence and cancer treatment. Biochim Biophys Acta 1775(1):5–20
Mooi WJ, Peeper DS (2006) Oncogene-induced cell senescence—halting on the road to cancer. N Engl J Med 355(10):1037–1046
Carnero A, Lleonart ME (2011) Epigenetic mechanisms in senescence, immortalisation and cancer. Biol Rev Camb Philos Soc 86(2):443–55
Ferbeyre G et al (2002) Oncogenic ras and p53 cooperate to induce cellular senescence. Mol Cell Biol 22(10):3497–3508
Demidenko ZN, Blagosklonny MV (2008) Growth stimulation leads to cellular senescence when the cell cycle is blocked. Cell Cycle 7(21):3355–3361
Blagosklonny MV (2010) Calorie restriction: decelerating mTOR-driven aging from cells to organisms (including humans). Cell Cycle 9(4):683–688
Castro ME et al (2008) PPP1CA contributes to the senescence program induced by oncogenic Ras. Carcinogenesis 29(3):491–499
Narita M, Lowe SW (2004) Executing cell senescence. Cell Cycle 3(3):244–246
Munoz-Espin D et al (2013) Programmed cell senescence during mammalian embryonic development. Cell 155(5):1104–1118
Storer M et al (2013) Senescence is a developmental mechanism that contributes to embryonic growth and patterning. Cell 155(5):1119–1130
Bueno MJ, Perez de Castro I, Malumbres M (2008) Control of cell proliferation pathways by microRNAs. Cell Cycle 7(20):3143–3148
Hartig SM et al (2015) The miRNA interactome in metabolic homeostasis. Trends Endocrinol Metab 26(12):733–745
Buhagiar A, Ayers D (2015) Chemoresistance, cancer stem cells, and miRNA influences: the case for neuroblastoma. Anal Cell Pathol 2015:150634
Loginov VI et al (2015) Methylation of miRNA genes and oncogenesis. Biochemistry 80(2):145–162
Wilczynska A, Bushell M (2015) The complexity of miRNA-mediated repression. Cell Death Differ 22(1):22–33
Dhahbi JM et al (2011) Deep sequencing reveals novel microRNAs and regulation of microRNA expression during cell senescence. PLoS One 6(5), e20509
Mercken EM et al (2013) Age-associated miRNA alterations in skeletal muscle from rhesus monkeys reversed by caloric restriction. Aging 5(9):692–703
Liu FJ, Wen T, Liu L (2012) MicroRNAs as a novel cellular senescence regulator. Ageing Res Rev 11(1):41–50
Chen LH et al (2010) MicroRNA and aging: a novel modulator in regulating the aging network. Ageing Res Rev 9(Suppl 1):S59–S66
Bueno MJ, Malumbres M (2011) MicroRNAs and the cell cycle. Biochim Biophys Acta 1812(5):592–601
Martinez I et al (2011) miR-29 and miR-30 regulate B-Myb expression during cellular senescence. Proc Natl Acad Sci U S A 108(2):522–527
Zhao JJ et al (2010) microRNA expression profile and identification of miR-29 as a prognostic marker and pathogenetic factor by targeting CDK6 in mantle cell lymphoma. Blood 115(13):2630–2639
Fabbri M, et al. (2007) MicroRNA-29 family reverts aberrant methylation in lung cancer by targeting DNA methyltransferases 3A and 3B. Proc Natl Acad Sci U S A. 104(40):15805–10.
Christoffersen NR et al (2010) p53-independent upregulation of miR-34a during oncogene-induced senescence represses MYC. Cell Death Differ 17(2):236–245
Bommer GT et al (2007) p53-mediated activation of miRNA34 candidate tumor-suppressor genes. Curr Biol 17(15):1298–1307
Tazawa H et al (2007) Tumor-suppressive miR-34a induces senescence-like growth arrest through modulation of the E2F pathway in human colon cancer cells. Proc Natl Acad Sci U S A 104(39):15472–15477
Marasa BS et al (2010) MicroRNA profiling in human diploid fibroblasts uncovers miR-519 role in replicative senescence. Aging 2(6):333–343
Noonan EJ et al (2010) miR-449a causes Rb-dependent cell cycle arrest and senescence in prostate cancer cells. Oncotarget 1(5):349–358
Noonan EJ et al (2009) miR-449a targets HDAC-1 and induces growth arrest in prostate cancer. Oncogene 28(14):1714–1724
Garzon R et al (2008) Distinctive microRNA signature of acute myeloid leukemia bearing cytoplasmic mutated nucleophosmin. Proc Natl Acad Sci U S A 105(10):3945–3950
Menghini R et al (2009) MicroRNA 217 modulates endothelial cell senescence via silent information regulator 1. Circulation 120(15):1524–1532
Borgdorff V et al (2010) Multiple microRNAs rescue from Ras-induced senescence by inhibiting p21(Waf1/Cip1). Oncogene 29(15):2262–2271
Voorhoeve PM et al (2006) A genetic screen implicates miRNA-372 and miRNA-373 as oncogenes in testicular germ cell tumors. Cell 124(6):1169–1181
Cho WJ et al (2009) miR-372 regulates cell cycle and apoptosis of ags human gastric cancer cell line through direct regulation of LATS2. Mol Cells 28(6):521–527
Leal JA, Feliciano A, Lleonart ME (2013) Stem cell microRNAs in senescence and immortalization: novel players in cancer therapy. Med Res Rev 33(1):112–38
Toledano H (2013) The role of the heterochronic microRNA let-7 in the progression of aging. Exp Gerontol 48(7):667–670
Saunders LR et al (2010) miRNAs regulate SIRT1 expression during mouse embryonic stem cell differentiation and in adult mouse tissues. Aging 2(7):415–431
Dellago H et al (2013) High levels of oncomiR-21 contribute to the senescence-induced growth arrest in normal human cells and its knock-down increases the replicative lifespan. Aging Cell 12(3):446–458
Zhu S et al (2013) MicroRNA-10A* and MicroRNA-21 modulate endothelial progenitor cell senescence via suppressing high-mobility group A2. Circ Res 112(1):152–164
Xu D et al (2011) miR-22 represses cancer progression by inducing cellular senescence. J Cell Biol 193(2):409–424
Yamada N et al (2014) Epigenetic regulation of microRNA-128a expression contributes to the apoptosis-resistance of human T-cell leukaemia jurkat cells by modulating expression of fas-associated protein with death domain (FADD). Biochim Biophys Acta 1843(3):590–602
Motohashi N et al (2013) Regulation of IRS1/Akt insulin signaling by microRNA-128a during myogenesis. J Cell Sci 126(Pt 12):2678–2691
Rudolf E, John S, Cervinka M (2012) Irinotecan induces senescence and apoptosis in colonic cells in vitro. Toxicol Lett 214(1):1–8
Motohashi N et al (2012) Identification of a novel microRNA that regulates the proliferation and differentiation in muscle side population cells. Stem Cells Dev 21(16):3031–3043
Mitomo S et al (2008) Downregulation of miR-138 is associated with overexpression of human telomerase reverse transcriptase protein in human anaplastic thyroid carcinoma cell lines. Cancer Sci 99(2):280–286
Itahana Y, Neo SH, Itahana K (2013) miR-141, a new player, joins the senescence orchestra. Cell Cycle 12(23):3586–3587
Yu KR et al (2013) MicroRNA-141-3p plays a role in human mesenchymal stem cell aging by directly targeting ZMPSTE24. J Cell Sci 126(Pt 23):5422–5431
Dimri M et al (2013) microRNA-141 regulates BMI1 expression and induces senescence in human diploid fibroblasts. Cell Cycle 12(22):3537–3546
Bhaumik D et al (2009) MicroRNAs miR-146a/b negatively modulate the senescence-associated inflammatory mediators IL-6 and IL-8. Aging 1(4):402–411
Bhaumik D, Patil CK, Campisi J (2009) MicroRNAs: an important player in maintaining a balance between inflammation and tumor suppression. Cell Cycle 8(12):1822
Lena AM et al (2012) MicroRNA-191 triggers keratinocytes senescence by SATB1 and CDK6 downregulation. Biochem Biophys Res Commun 423(3):509–514
Foja S et al (2013) Hypoxia supports reprogramming of mesenchymal stromal cells via induction of embryonic stem cell-specific microRNA-302 cluster and pluripotency-associated genes. Cell Reprogram 15(1):68–79
Lin SL, Ying SY (2013) Mechanism and method for generating tumor-free iPS cells using intronic microRNA miR-302 induction. Methods Mol Biol 936:295–312
Kelley K, Lin SL (2012) Induction of somatic cell reprogramming using the microRNA miR-302. Prog Mol Biol Transl Sci 111:83–107
Tome M et al (2014) miR-335 correlates with senescence/aging in human mesenchymal stem cells and inhibits their therapeutic actions through inhibition of AP-1 activity. Stem Cells 32(8):2229–2244
Bai XY et al (2011) miR-335 and miR-34a Promote renal senescence by suppressing mitochondrial antioxidative enzymes. J Am Soc Nephrol 22(7):1252–1261
Duale N et al (2007) Molecular portrait of cisplatin induced response in human testis cancer cell lines based on gene expression profiles. Mol Cancer 6:53
Song J et al (2015) miR-370 and miR-373 regulate the pathogenesis of osteoarthritis by modulating one-carbon metabolism via SHMT-2 and MECP-2, respectively. Aging Cell 14(5):826–837
Wei F et al (2015) Diverse functions of miR-373 in cancer. J Transl Med 13:162
Gorospe M et al (2011) Post-transcriptional control of the hypoxic response by RNA-binding proteins and microRNAs. Front Mol Neurosci 4:7
Acknowledgments
This work was supported by grants from the Spanish Ministry of Economy and Competitiveness, Plan Nacional de I + D + I 2008-2011, Plan Estatal de I + D + I 2013–2016, ISCIII (Fis: PI12/00137, PI15/00045, RTICC: RD12/0036/0028) co-funded by FEDER from Regional Development European Funds (European Union), Consejeria de Ciencia e Innovacion (CTS-6844 and CTS-1848), and Consejeria de Salud of the Junta de Andalucia (PI-0135-2010, PI-0306-2012 and PI-0096-2014).
Author information
Authors and Affiliations
Corresponding authors
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2017 Springer Science+Business Media New York
About this protocol
Cite this protocol
Guijarro, M.V., Carnero, A. (2017). Genome-Wide miRNA Screening for Genes Bypassing Oncogene-Induced Senescence. In: Nikiforov, M. (eds) Oncogene-Induced Senescence. Methods in Molecular Biology, vol 1534. Humana Press, New York, NY. https://doi.org/10.1007/978-1-4939-6670-7_5
Download citation
DOI: https://doi.org/10.1007/978-1-4939-6670-7_5
Published:
Publisher Name: Humana Press, New York, NY
Print ISBN: 978-1-4939-6668-4
Online ISBN: 978-1-4939-6670-7
eBook Packages: Springer Protocols